Researchers at the University of Manchester and The Christie cancer hospital are leveraging artificial intelligence to simulate clinical trials, significantly enhancing the speed, safety, and cost-effectiveness of cancer research. With a £5.9 million funding boost from Cancer Research UK, this innovative approach uses real-life data to create virtual patients, allowing for precise testing of radiotherapy treatments. This collaboration aims to develop AI algorithms for personalized radiotherapy, improving treatment outcomes and reducing side effects, while also accelerating research and innovation in cancer care.